cushieblog.com
Pasireotide Reduces Pituitary Tumor Volume in Cushing’s Disease
Lacroix A, et al. Pituitary. 2019;doi:10.1007/s11102-019-01021-2. January 7, 2020 Andre Lacroix Most adults with persistent or recurrent Cushing’s disease treated with the somatostatin analogue pas…